Hector多分支胸主动脉支架系统及连接支架在主动脉弓腔内修复中的解剖适用性
本研究为单中心回顾性临床前研究,纳入1999至2024年间539例主动脉弓病变腔内治疗患者中的79例,评估Hector多分支装置及其连接支架的解剖适用性。结果显示50例(63.2%)适合植入,使用其他桥接支架后升至54例(68.4%);左颈总动脉桥接支架适用于全部适合患者,左锁骨下动脉桥接支架适用率为92.6%。
要点
- Hector装置在63.2%的主动脉弓腔内治疗患者中解剖适用,使用其他桥接支架后达68.4%。
- 左颈总动脉桥接支架适用于所有适合患者,左锁骨下动脉桥接支架适用率为92.6%。
- 近端锚定区缩短与非适用性风险增加相关(OR=1.05,p=0.015)。
核心结论
- Hector支架系统联合市售桥接支架在超过三分之二的主动脉弓病变腔内治疗患者中解剖可行。
- 左颈总动脉桥接支架适用于全部适合患者,左锁骨下动脉桥接支架约九成适用。
研究设计与样本
- 单中心、回顾性、临床前研究,纳入1999至2024年间539例主动脉弓病变腔内治疗患者中的79例。
- 装置及连接支架适用性依据制造商使用说明书定义,并评估扩展适用性。
主要发现
- 50例(63.2%)适合植入Hector装置,使用其他可用桥接支架后升至54例(68.4%)。
- 约半数合格患者可使用14种配置进行治疗。
- 左颈总动脉桥接支架适用于全部适合患者,左锁骨下动脉桥接支架适用率为92.6%。
- 近端锚定区缩短与非适用性风险增加相关(OR=1.05,p=0.015)。
- 头臂干长度每增加1毫米,适用性几率增加6%(OR=1.06,p=0.046)。
关键数值与推荐
- 适用性定义依据制造商使用说明书。
- 扩展适用性包括因限制性解剖标准被排除的患者。
临床怎么用
- Hector装置可用于多数主动脉弓病变的完全腔内修复,左颈总动脉桥接支架适用性高。
- 近端锚定区较短时需谨慎评估解剖适用性。
局限性
- 单中心回顾性临床前研究,样本量有限(79例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Endovascular repair of the aortic arch has emerged as an alternative to open surgery, particularly for high-risk and elderly patients. While multibranched endografts have demonstrated technical success, anatomical suitability remains a key limiting factor, especially given the variability of arch anatomy. The aim of the present study is to evaluate the suitability of the Hector multibranch device in a cohort of patients who underwent endovascular treatment for aortic arch's lesions. METHODS: A total of 539 patients were treated between 1999 and 2024, with 79 included in a single-center, retrospective, preclinical study. The suitability for device and its connecting stent was defined according to the manufacturer's instructions for use. Extended suitability was also evaluated, including patients excluded for limiting anatomical criteria. Secondary outcomes were suitable and non-suitable patients' comparison, exclusion causes analysis, and anatomical characteristics associated with suitability. A logistic regression model assessed associations between baseline and non-suitability. RESULTS: A total of 50 patients (63.2%) were suitable for implantation, raising to 54 (68.4%) by using other available bridging stents. Approximately half of the eligible patients could have been treated using 14 configurations for the analyzed device. The left common carotid artery bridging stent was appropriate for all suitable patients, while the appropriateness rate for the left subclavian artery stent was 92.6%. The odds of non-feasibility increased with proximal landing zone shortening (OR=1.05, p=0.015), whereas each additional millimeter in BCT length increased the odds of suitability by 6% (OR=1.06, p=0.046). CONCLUSIONS: The Hector Stent Graft system coupled with commercially available bridging stents for supra-aortic trunks proved to be feasible for more than two-thirds of patients previously subjected to an endovascular treatment for aortic arch pathologies. The left common carotid artery bridging stent was suitable for all patients, while the one for the left subclavian artery was adequate for 9 out of 10 cases.Clinical ImpactThe Hector™ Stent Graft system shows high anatomical feasibility for endovascular aortic arch repair, with broad applicability using limited configurations. Its design may help minimize supra-aortic-trunks manipulation and facilitate safer, more streamlined procedures to treat the aortic arch pathologies in a complete endovascular fashion.
引用
- Leone N, Bartolotti LAM, Andreoli F, et al. Anatomical Viability of the "Hector Multibranched Thoracic Stent-Graft System" and Connecting Stent for Endovascular Aortic Arch Repair. J Endovasc Ther. 2026. PMID: 41587765. doi:10.1177/15266028251401192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。